Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02553421 · ClinicalTrials.gov registry record · NA
Optical Detection of Intravenous Infiltration:A Pilot Study
A NA study, sponsored by ivWatch.
- Completed
- Registry status
- NA
- Development phase
- 243
- Enrollment target
NCT02553421 is a NA study that has completed, run by ivWatch. The registered enrollment target is 243 participants.
The verdict
NCT02553421, a NA study, has completed, sponsored by ivWatch.
- COMPLETED
- Registry status
- NA
- Development phase
- 243 participants
- Enrollment target
Study Summary
This study will examine the use of the ivWatch Model 400 to monitor PIV sites in pediatric patients. Half the participants will be monitored by the device without infiltration notifications and the other half will be monitored by the device with infiltration notifications enabled.
Interventions
- DEVICE ivWatch Model 400
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 243 participants |
| Start Date | 2015-08 |
| Est. Completion | 2016-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02553421
The ClinicalTrials.gov registry entry for NCT02553421 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 243 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ivWatch, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ivWatch Model 400 is the first listed.
NCT02553421 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02553421 about?
NCT02553421 is a clinical study titled "Optical Detection of Intravenous Infiltration:A Pilot Study". This study will examine the use of the ivWatch Model 400 to monitor PIV sites in pediatric patients. Half the participants will be monitored by the device without infiltration notifications and the other half will be monitored by the device with infiltration notifications enabled.
What is the current status of trial NCT02553421?
This trial is currently completed. It is a NA study. The enrollment target is 243 participants. The study started on 2015-08. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02553421?
The interventions under investigation include: ivWatch Model 400 (DEVICE).
Who is sponsoring clinical trial NCT02553421?
This trial is sponsored by ivWatch, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.